Physician profile
Joseph B Sugg
NPI 1285862862
$1,128.96
in general payments reported to CMS, 2019-2025
11 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.84 · 2020: $65.00 · 2021: $170 · 2022: $129 · 2023: $247 · 2024: $250 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $477.24 | 2022-2025 | Ce-Marked Kxla System, Idosetr, Photrexa Viscous and Photrexa |
| Alcon Vision LLC | $161.96 | 2019-2024 | Total30, Precision 7 |
| Allergan, INC. | $140.16 | 2021 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $63.86 | 2023-2024 | Acuvue |
| Oyster Point Pharma, INC. | $51.14 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $42.25 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $39.45 | 2024 | Xiidra, Miebo |
| Lombart Brothers, INC. | $35.07 | 2025 | Opd-III |
| Novartis Pharmaceuticals Corporation | $31.59 | 2023 | |
| Biotissue Holdings INC. | $20.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Sugg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.